Bone Marrow Collection in Healthy Volunteers (iCell)
NCT02118740 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2017-01-30
Summary
This is a observational study in which healthy found volunteers are recruited to donate 50 ml of bone marrow aspirate to enable preclinical studies to obtain proof of concept and safety of a bone marrow derived stem cell preparation named AMARCELL. The prepared AMARCELL is only for animal studies and after completion of the preclinical program, the intention of AMARCELL is to treat humans with a traumatic Spinal cord injury.
Conditions
- Spinal Cord Injury
Sponsors & Collaborators
-
Neuroplast
collaborator INDUSTRY -
Amarna Stem Cells BV
lead INDUSTRY
Principal Investigators
-
Harry Steinbusch, Prof.dr. · University Maastricht
-
Gerard Bos, Prof.dr. · Maastricht University Medical Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2017-12-30
- Completion
- 2018-04-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Treatment for Acute Spinal Cord Injury
NCT00695149 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Collection of Bone Marrow Aspirate From Volunteer Donors
NCT00183066 ·Status: COMPLETED
-
Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury
NCT04528550 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
NCT00859014 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
NCT00535197 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Feasability Study of Autologous Bone Marrow Aspirate Concentrate for Treatment of CLI
NCT00595257 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in SCI
NCT02165904 ·Status: COMPLETED ·Phase: PHASE1
-
Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury
NCT04331405 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
NCT01071577 ·Status: TERMINATED
-
Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury
NCT05671796 ·Status: UNKNOWN ·Phase: PHASE2
-
Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke
NCT01501773 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury
NCT02237547 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Cord Blood Cells in Patients With Acute SCI
NCT05693181 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
NCT01297413 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients
NCT01028794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Collection for Adult Volunteers
NCT00033774 ·Status: TERMINATED
-
Autologous Bone Marrow Mononuclear Cell Implantation for Moderate to Severe Peripheral Arterial Disease
NCT00919516 ·Status: COMPLETED ·Phase: NA
-
Autologous Bone Marrow For Lower Extremity Ischemia Treating
NCT00753025 ·Status: COMPLETED ·Phase: PHASE2
-
Intraspinal Transplantation of Autologous ADRC in ALS Patients
NCT03296501 ·Status: UNKNOWN ·Phase: PHASE1
-
Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury
NCT02574585 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Autologous Bone Marrow Concentrate for the Treatment of Critical Limb Ischemia (CLI)
NCT00498069 ·Status: COMPLETED ·Phase: NA
-
Bone Marrow Cells in Myocardial Infarction
NCT00363324 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment
NCT01572376 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI)
NCT01245335 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct
NCT01461720 ·Status: UNKNOWN ·Phase: PHASE2